These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20160229)

  • 1. Dissimilar neuropsychiatric presentations of two siblings with juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Lee TS; Poon SH; Chang P
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):123.E14-5. PubMed ID: 20160229
    [No Abstract]   [Full Text] [Related]  

  • 2. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.
    Ragbeer SN; Augustine EF; Mink JW; Thatcher AR; Vierhile AE; Adams HR
    J Child Neurol; 2016 Mar; 31(4):481-7. PubMed ID: 26336202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is myopathy with rimmed vacuoles a hallmark of juvenile neuronal ceroid lipofuscinosis (CLN3)?
    Borgione E; Castello F; Lo Giudice M; Santa Paola S; Salvatore S; Berti G; Malandrini A; Bottitta M; Musumeci SA; Scuderi C
    Neurol Sci; 2016 May; 37(5):805-7. PubMed ID: 26700800
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic delusions. Diagnosis, development, treatment].
    Allio G; Petit M
    Rev Prat; 2000 Jun; 50(11):1239-44. PubMed ID: 11008507
    [No Abstract]   [Full Text] [Related]  

  • 11. Next-Generation Sequencing in the Diagnosis of Juvenile Neuronal Ceroid Lipofuscinosis.
    Deacon BS; Charles JM; Cheeseman EW; Cathey SS
    Pediatr Neurol; 2016 Sep; 62():71-2. PubMed ID: 27215405
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic linkage analysis of a variant of juvenile onset neuronal ceroid lipofuscinosis with granular osmiophilic deposits.
    O'Rawe A; Mitchison HM; Williams R; Wheeler R; Andermann E; Andermann F; Hart YM; Martin JJ; Philippart M; Stephenson JB; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):21-2. PubMed ID: 9151314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease).
    Drack AV; Mullins RF; Pfeifer WL; Augustine EF; Stasheff SF; Hong SD
    Ophthalmic Genet; 2015; 36(4):359-64. PubMed ID: 24547931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaesthesia and orphan disease: a child with neuronal ceroid lipofuscinosis.
    Richa F
    Eur J Anaesthesiol; 2015 Mar; 32(3):213-5. PubMed ID: 24979587
    [No Abstract]   [Full Text] [Related]  

  • 16. Juvenile neuronal ceroid lipofuscinoses.
    Wang S
    Adv Exp Med Biol; 2012; 724():138-42. PubMed ID: 22411240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course.
    Aberg L; Lauronen L; Hämäläinen J; Mole SE; Autti T
    Pediatr Neurol; 2009 Feb; 40(2):134-7. PubMed ID: 19135632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Unusual Presentation of CLN3-Associated Batten Disease With Classic Histopathologic and Ultrastructural Findings.
    Evans LP; Gibson-Corley KN; Mullins RF; Tucker BA; Trent A; Stone EM; Jones KA
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1081–1084. PubMed ID: 34313756
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Adams HR; Beck CA; Levy E; Jordan R; Kwon JM; Marshall FJ; Vierhile A; Augustine EF; de Blieck EA; Pearce DA; Mink JW
    Dev Med Child Neurol; 2010 Jul; 52(7):637-43. PubMed ID: 20187884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations.
    Wisniewski KE; Kaczmarski A; Kida E; Connell F; Kaczmarski W; Michalewski MP; Moroziewicz DN; Zhong N
    Mol Genet Metab; 1999 Apr; 66(4):248-52. PubMed ID: 10191110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.